"The Pioneers of Cell Based Technology and Micro-Encapsulation"
ALTUCELL LOGO 24/7 SUPPORT: 631 586-4940
FAX: 631 586-4942 
Breaking News! Altucell Releases Evidence in Support of Microencapsulated Sertoli Cells for Reversal of Diabetes

October 31, 2016 By Cade Hildreth (CEO)

Diabetes is a chronic disease that both reduces life expectancy and reduces quality of life among the afflicted.

According to the Center for Disease Control (CDC), 29.1 million people or 9.3% of the U.S. population has diabetes, including an estimated 8.1 million who are undiagnosed. According to the American Diabetes Association, the “2012 cost of this disease in the U.S. was $245 billion per annum or approximately $500,000 every minute.”

AltuCell Diabetes Treatment

Additionally, nearly 90% of those patients are afflicted by type 2 or “insulin resistant” diabetes. Specifically, the World Health Organization (WHO) estimates that 90% of people around the world who are afflicted by diabetes suffer from type 2 diabetes.

Therefore, progress with a cell therapy based approach for the treatment diabetes would represent a global medical breakthrough.

JEM Publication
JEM-The Rockefeller University


Therapy of experimental type 1 Diabetes by isolated sertoli cell xenografts alone.


Type I diabetes mellitus is caused by autoimmune destruction of pancreatic β cells, and effective treatment of the disease might require rescuing β cell function in a context of reinstalled immune tolerance. Sertoli cells (SCs) are found in the testes, where their main task is to provide local immunological protection and nourishment to developing germ cells. SCs engraft, self-protect, and coprotect allogeneic and xenogeneic grafts from immune destruction...

»   For more info on this and other topics go to our [pulbications] page.

reaching to cure diabetes

Each year, more than 13,000 children are diagnosed with type 1 Diabetes. Diabetes is one of the most common chronic diseases in children and adolescents; ALTuCELL’s mission is to find a cure for insulin-dependent diabetes. The company, and its collaborative relationships with leaders in the field, developed because of a personal commitment of the founder Gary Harlem: the promise made to seek a cure for his son diagnosed with Type 1 Diabetes. Along the way the Harlem family has attracted interest, support and encouragement from other families and leading scientists alike who are affected by Diabetes.

ALTuCELL believes that the true path to eradication of this horrible disease which affects millions of children every year, is to alter the immune system, which itself has turned on, that has caused damage to specific cell types of pancreatic islets cluster of cells that produce insulin and other metabolic hormones. After extensive research, traveling across the globe and having meetings and communications throughout the world, Harlem has found the most practical, proficient and logical approach to deliver results and remedying this debilitating disease. ALTuCELL, Inc hopes to eliminate the need for insulin injections through this advanced therapy. Since insulin injections alone may attenuate, but not eliminate the risk for developing major complications of type 1 diabetes, at level of kidneys, cardiovascular system, nervous system and eyes. there is the unmet need for a cure.